HB9598: Office of National Drug Control Policy Reauthorization Act of 2024

Introduced in House

Referred to the Committee on Oversight and Accountability, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Consideration and Mark-up Session Held

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 38 - 0.

Mr. Comer moved to suspend the rules and pass the bill, as amended.

Considered under suspension of the rules. (consideration: CR H6319-6324)

DEBATE - The House proceeded with forty minutes of debate on H.R. 9598.

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Considered as unfinished business. (consideration: CR H6395-6396)

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 399 - 1 (Roll no. 485). (text: 12/4/2024 CR H6319-6322)

Motion to reconsider laid on the table Agreed to without objection.

Received in the Senate and Read twice and referred to the Committee on the Judiciary.